Clinical Trials Directory

Trials / Terminated

TerminatedNCT00469963

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Clinical Trial of Sir Spheres® in Patients With Primary Hepatocellular Carcinoma

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Specialized internal radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This clinical trial is studying how well internal radiation therapy works in treating patients with primary liver cancer that cannot be removed by surgery.

Detailed description

OBJECTIVES: Primary * Determine tumor response to selective internal radiation therapy comprising yttrium Y 90 resin microspheres (Sir-Spheres®) in patients with unresectable primary hepatocellular carcinoma. Secondary * Determine the toxicity of this regimen in these patients. * Determine the health-related quality of life of patients receiving this regimen. * Determine the survival of patients receiving this regimen. OUTLINE: Patients undergo selective internal radiation therapy comprising yttrium Y 90 resin microspheres (Sir-Spheres®) via catheter directly into the hepatic artery on day 1. Health-related quality of life is assessed prior to initial treatment and then periodically thereafter. After completion of study treatment, patients are followed periodically for 12-24 months. PROJECTED ACCRUAL: A total of 35 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
PROCEDUREquality-of-life assessmentquality-of-life assessment
RADIATIONyttrium Y 90 resin microspheresradiation therapy

Timeline

Start date
2003-12-01
Primary completion
2006-10-01
Completion
2007-04-01
First posted
2007-05-07
Last updated
2012-09-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00469963. Inclusion in this directory is not an endorsement.